s6y
Company name or ticker
Search
Compass Therapeutics, Inc.
424B5
Prospectus filed pursuant to Rule 424(b)(5)
Filed
Wednesday, November 3, 2021
Accession number
0001193125-21-318640
Documents
424B5
424B5
On sec.gov
Filing index
All files
Complete submission text
SGML header